Ind-Swift Laboratories Limited
NSE: INDSWFTLAB BSE: INDSWFTLAB
NSE
97.98
-1.64 (-1.65%)
Prev Close
99.62
Open Price
100
Volume
37,828
Today Low / High
96.35 / 100.6
52 WK Low / High
68.72 / 158.56
Range
93 - 103
BSE
98.30
-2.15 (-2.14%)
Prev Close
100.45
Open Price
99
Volume
3,898
Today Low / High
97.1 / 100.3
52 WK Low / High
67.15 / 160
Range
93 - 103
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 97.98 (target range: 93 - 103), reflecting a change of -1.64 (-1.64626%). On the BSE, it is listed at 98.3 (target range: 93 - 103), showing a change of -2.15 (-2.14037%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
08 Aug
102.85
-3.60%
07 Aug
98.02
2.40%
06 Aug
103.00
-2.72%
05 Aug
104.99
-2.76%
04 Aug
106.67
-2.90%
01 Aug
106.00
0.63%
31 Jul
104.50
0.48%
30 Jul
104.01
1.12%
29 Jul
105.00
0.70%
28 Jul
105.00
-0.30%
Ind-Swift Laboratories Limited Graph
Ind-Swift Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Ind-Swift Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 97.98, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 98.30 | 99.28 | 89.35 - 109.21 |
| 100.27 | 80.21 - 120.32 | ||
| 101.25 | 70.87 - 131.62 | ||
| Bearish Scenario | 98.30 | 97.32 | 87.59 - 107.05 |
| 96.33 | 77.07 - 115.60 | ||
| 95.35 | 66.75 - 123.96 |
Overview of Ind-Swift Laboratories Limited
ISIN
INE915B01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
388,143
Market Cap
6,010,363,935
Last Dividend
0
Official Website
IPO Date
2002-07-01
DCF Diff
-129.84
DCF
229
Financial Ratios Every Investor Needs
Stock Dividend of INDSWFTLAB
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2011-09-20 | September 20, 11 | 1 | 1 | 2011-09-21 | 2011-10-26 | 2011-05-25 |
| 2010-09-16 | September 16, 10 | 1 | 1 | 2010-09-18 | 2010-10-22 | 2010-05-29 |
| 2009-09-17 | September 17, 09 | 1 | 1 | 2009-09-19 | 2009-10-24 | 2009-06-29 |
| 2008-09-18 | September 18, 08 | 1 | 1 | 2008-09-22 | 2008-11-01 | 2008-06-19 |
| 2007-09-21 | September 21, 07 | 1 | 1 | 2007-09-25 | 2007-11-01 | 2007-07-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,280.90 Cr | 867.58 Cr | 413.32 Cr | 0.3227 | 0.00 Cr | 36.78 Cr | 200.90 Cr | 420.96 Cr | 71.24 | 686.16 Cr | 0.3286 |
| 2023-03-31 | 1,207.31 Cr | 766.86 Cr | 440.45 Cr | 0.3648 | 42.57 Cr | 20.52 Cr | 181.52 Cr | 47.60 Cr | 8.06 | 235.77 Cr | 0.0394 |
| 2022-03-31 | 1,038.73 Cr | 629.12 Cr | 409.61 Cr | 0.3943 | 32.72 Cr | 20.41 Cr | 92.42 Cr | -2.15 Cr | -0.36 | 239.12 Cr | -0.0021 |
| 2021-03-31 | 891.34 Cr | 516.24 Cr | 375.10 Cr | 0.4208 | 33.01 Cr | 15.95 Cr | 110.96 Cr | -3.15 Cr | -0.53 | 198.25 Cr | -0.0035 |
| 2020-03-31 | 779.64 Cr | 396.66 Cr | 382.98 Cr | 0.4912 | 5.92 Cr | 17.38 Cr | 73.13 Cr | -21.19 Cr | -4.28 | 177.54 Cr | -0.0272 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 431.93 Cr | 1,165.11 Cr | 233.67 Cr | 936.1773 Cr | 16.62 Cr | -415.31 Cr | 10.46 Cr | 5.36 Cr | 5.35 Cr | 0.00 Cr | 110.54 Cr | 216.5571 Cr |
| 2023-03-31 | 18.20 Cr | 1,824.06 Cr | 1,142.13 Cr | 681.9307 Cr | 862.10 Cr | 843.90 Cr | 438.60 Cr | 592.75 Cr | 0.00 Cr | 0.12 Cr | 25.38 Cr | 371.0889 Cr |
| 2022-03-31 | 21.48 Cr | 1,800.79 Cr | 1,199.93 Cr | 600.9723 Cr | 953.02 Cr | 931.54 Cr | 428.50 Cr | 636.84 Cr | 0.00 Cr | 0.00 Cr | 29.06 Cr | 334.4653 Cr |
| 2021-03-31 | 11.60 Cr | 1,818.45 Cr | 1,215.03 Cr | 603.5061 Cr | 1,005.35 Cr | 993.75 Cr | 375.67 Cr | 748.09 Cr | 0.00 Cr | 0.17 Cr | 35.53 Cr | 314.5231 Cr |
| 2020-03-31 | 10.58 Cr | 1,870.01 Cr | 1,229.37 Cr | 640.6356 Cr | 1,031.32 Cr | 1,020.74 Cr | 342.82 Cr | 854.49 Cr | 0.00 Cr | 0.00 Cr | 17.45 Cr | 323.0685 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -163.1152 Cr | -122.6903 Cr | 698.9138 Cr | -207.6321 Cr | 413.2799 Cr | 431.4797 Cr | -44.5169 Cr | 420.9616 Cr | -37.4278 Cr | 0.0000 Cr | 32.8866 Cr |
| 2023-03-31 | 194.6196 Cr | -13.3683 Cr | -185.6574 Cr | 181.8489 Cr | -4.4061 Cr | 17.0715 Cr | -12.7707 Cr | 113.1690 Cr | -45.9089 Cr | 0.0000 Cr | -10.1029 Cr |
| 2022-03-31 | 150.2741 Cr | 4.7722 Cr | -140.8769 Cr | 131.8592 Cr | 14.1694 Cr | 25.7700 Cr | -18.4149 Cr | 12.5324 Cr | -36.0118 Cr | 0.0000 Cr | -52.8337 Cr |
| 2021-03-31 | 134.9471 Cr | -10.1716 Cr | -123.7469 Cr | 130.5505 Cr | 1.0287 Cr | 11.6110 Cr | -3.9104 Cr | 18.0085 Cr | -39.8529 Cr | 0.0000 Cr | -32.8484 Cr |
| 2020-03-31 | 125.2380 Cr | -9.0985 Cr | -133.2590 Cr | 114.0724 Cr | -17.1195 Cr | 12.8485 Cr | -10.7431 Cr | -19.7712 Cr | -65.7422 Cr | 0.0000 Cr | -26.2088 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 8.66 Cr | 6.22 Cr | 2.45 Cr | 0.2822 | -14.78 Cr | 0.01 Cr | 0.00 | -0.72 Cr | 0.0007 |
| 2024-09-30 | 11.96 Cr | 8.31 Cr | 3.64 Cr | 0.3048 | -12.01 Cr | 0.41 Cr | 0.07 | 1.21 Cr | 0.0346 |
| 2024-06-30 | 33.17 Cr | 33.65 Cr | -0.48 Cr | -0.0145 | -9.99 Cr | 0.94 Cr | 0.16 | 1.40 Cr | 0.0282 |
| 2024-03-31 | 393.33 Cr | 365.06 Cr | 28.27 Cr | 0.0719 | -49.97 Cr | 238.82 Cr | 40.42 | 386.01 Cr | 0.6072 |
| 2023-12-31 | 287.51 Cr | 155.44 Cr | 132.08 Cr | 0.4594 | 38.13 Cr | 19.42 Cr | 3.29 | 58.80 Cr | 0.0675 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 438.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,011.52 Cr |
| 2024-09-30 | 438.46 Cr | 0.00 Cr | 438.46 Cr | 0.00 Cr | 9.33 Cr | 586.80 Cr | 5.02 Cr | 1,188.02 Cr | 176.50 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 431.93 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -931.44 Cr |
| 2024-03-31 | 431.93 Cr | 2.79 Cr | 431.93 Cr | 169.12 Cr | 10.46 Cr | 661.13 Cr | 5.36 Cr | 1,165.11 Cr | 233.67 Cr |
| 2023-12-31 | -13.20 Cr | 26.41 Cr | 13.20 Cr | 0.00 Cr | 0.00 Cr | 13.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.41 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 238.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 19.42 Cr | 27.11 Cr | 0.00 Cr | 0.00 Cr | 27.11 Cr | 40.32 Cr | 13.20 Cr | 0.00 Cr | 27.11 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,641.80 | ₹3,939,137,904,000.00 | ₹2,098,280.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,151.50 | ₹1,633,032,553,500.00 | ₹681,521.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,685.30 | ₹1,247,271,358,500.00 | ₹279,863.00 |
| Mankind Pharma Limited | MANKIND | ₹2,606.80 | ₹1,075,901,331,568.00 | ₹731,305.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,277.60 | ₹1,063,387,459,020.00 | ₹1,229,762.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.80 | ₹994,960,224,000.00 | ₹307,413.00 |
| Lupin Limited | LUPIN | ₹1,974.70 | ₹901,938,300,900.00 | ₹380,522.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,426.00 | ₹648,759,690,000.00 | ₹99,581.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,050.40 | ₹610,074,420,800.00 | ₹1,872,840.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,937.30 | ₹546,707,997,300.00 | ₹466,930.00 |
| Laurus Labs Limited | LAURUSLABS | ₹879.10 | ₹474,560,157,500.00 | ₹1,548,001.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,418.40 | ₹359,853,753,600.00 | ₹437,395.00 |
| Cohance Lifesciences Limited | COHANCE | ₹884.70 | ₹338,457,031,978.00 | ₹105,334.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,638.50 | ₹329,643,636,000.00 | ₹49,045.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,747.90 | ₹273,268,433,900.00 | ₹250,994.00 |
| Piramal Enterprises Limited | PEL | ₹1,167.70 | ₹264,691,900,600.00 | ₹183,898.00 |
| Eris Lifesciences Limited | ERIS | ₹1,768.70 | ₹240,909,320,900.00 | ₹37,828.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,479.40 | ₹240,371,432,600.00 | ₹246,819.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,433.00 | ₹210,825,000,000.00 | ₹11,150.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹974.60 | ₹191,570,299,800.00 | ₹29,498.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,888.00 | ₹178,181,651,200.00 | ₹28,474.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,083.00 | ₹172,501,323,000.00 | ₹140,398.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,168.10 | ₹164,800,966,770.00 | ₹172,510.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹882.45 | ₹158,055,619,500.00 | ₹259,072.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹458.50 | ₹111,252,274,000.00 | ₹945,550.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,581.50 | ₹109,248,951,100.00 | ₹46,177.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹851.90 | ₹83,308,067,710.00 | ₹36,218.00 |
| Strides Pharma Science Limited | STAR | ₹865.50 | ₹79,775,471,850.00 | ₹92,326.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹863.25 | ₹78,240,335,715.00 | ₹294,141.00 |
| FDC Limited | FDC | ₹474.65 | ₹77,277,766,500.00 | ₹198,253.00 |
| Innova Captab Limited | INNOVACAP | ₹911.35 | ₹52,151,939,956.00 | ₹70,484.00 |
| Suven Life Sciences Limited | SUVEN | ₹230.75 | ₹50,320,575,500.00 | ₹56,095.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹146.08 | ₹47,406,173,760.00 | ₹195,028.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹483.05 | ₹44,087,973,500.00 | ₹160,106.00 |
| Sequent Scientific Limited | SEQUENT | ₹175.85 | ₹44,021,409,750.00 | ₹240,104.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹772.20 | ₹39,165,289,020.00 | ₹31,316.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,358.20 | ₹39,002,269,800.00 | ₹5,512.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹363.25 | ₹36,425,983,500.00 | ₹39,528.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹502.80 | ₹35,400,036,240.00 | ₹9,585.00 |
| Hikal Limited | HIKAL | ₹254.90 | ₹31,429,424,900.00 | ₹3,140,867.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹631.60 | ₹30,413,434,800.00 | ₹53,855.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹96.82 | ₹28,419,284,140.00 | ₹848,541.00 |
| Alembic Limited | ALEMBICLTD | ₹105.52 | ₹27,095,636,534.00 | ₹249,022.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹49.03 | ₹26,866,184,620.00 | ₹2,369,065.00 |
| Indoco Remedies Limited | INDOCO | ₹279.55 | ₹25,787,900,445.00 | ₹12,570.00 |
Key Executives
Executive Director
Mr. Sahil Munjal
Gender: male
Year Born: 1980
Senior Vice President of Marketing
Varun Chhabra
Gender: Not Specified
Year Born:
Chief Financial Officer
Mr. Gagan Aggarwal
Gender: male
Year Born:
Group HR Head
Akashdeep Sharma
Gender: Not Specified
Year Born:
Executive Director
Mr. Rishav Mehta
Gender: male
Year Born: 1991
General Manager of Information & Technology
Ashok Kothari
Gender: Not Specified
Year Born:
Joint MD & Whole Time Director
Mr. Himanshu Jain BCom
Gender: male
Year Born: 1982
Chairman & MD
Mr. Navrattan R. Munjal
Gender: male
Year Born: 1952
Vice President of Corporate Affairs, Compliance Officer & Company Secretary
Mr. Pardeep Verma
Gender: male
Year Born:
FAQs about Ind-Swift Laboratories Limited
Who is the CEO of the company?
The CEO is Navrattan R. Munjal.
What is the current market price of the stock?
The current price is ₹99.15.
What is the 52-week price range?
The range is ₹68.72-177.94.
What is the market capitalization of the company?
The market capitalization is ₹601.04 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 2.44.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Ind-Swift Laboratories Limited (ISIN: INE915B01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹601.04 crores and an average daily volume of 388,143 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.